{"name":"Dermatrials Research","slug":"dermatrials-research","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"tretinoin microsphere 0.04% gel","genericName":"tretinoin microsphere 0.04% gel","slug":"tretinoin-microsphere-0-04-gel","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"tretinoin microsphere 0.04% gel","genericName":"tretinoin microsphere 0.04% gel","slug":"tretinoin-microsphere-0-04-gel","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiP0FVX3lxTE1vSzZ5WHhaUWZIa3pPNXBsaVFLbXBkSzMyeDE5amJPMk9rb2JpWDEwNTJDVF9pbks1VG9kakRlNA?oc=5","date":"2022-11-21","type":"pipeline","source":"NewCa.com","summary":"NewCa.com Documents - NewCa.com","headline":"NewCa.com Documents","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNWFpYT0p0bV9YN0NLNHJ0S2o1WV9iN2gtS2hwN0lyQzBYbEFSQU5sVVRVeGVJQTBrM2ZIbDEtd3hzMExhdEdreGg2Y1FMbzNWcVJLVXZ1Nkd3UzBIZEdIby1idzh2MzZuTFFDdS1aa3Z5Q1pCeUNKOEs1T2JBVDBYQXpRXzI0MERuOVd0WUxmaWthTXdhMHRNMUVzYnRTQURpRWRMT2NOdUhOdERLUGNTZWF3a2VqbDM5ZWFqT0RhSHRScThmM3MzdjhPaUtMTlhfTWhnS1Z6dVAxOU1LU1ZvTWtNTWxzbTVKX0NSdkE3RnBUeDNqUjlSMHREc3pJMEZJTUlRN2M1ZTlUeUZjd0ZZWkNpZFcteXhS?oc=5","date":"2022-11-15","type":"patent","source":"newswire.ca","summary":"The JAMP Pharma Group launches PrJAMP Apremilast, a new generic alternative for the treatment of plaque psoriasis and psoriatic arthritis - newswire.ca","headline":"The JAMP Pharma Group launches PrJAMP Apremilast, a new generic alternative for the treatment of plaque psoriasis and ps","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQTDdmOTVVSDItZFVRcGEwbUI0ZEJlVWlNNnRFZGkzaXB1b2lDODhqaF9rQ1lNUEJYQk9Ecjl4ZlRIamU0NHJVX29xV3VyRnRZaTBOU1BWNXQ2aE9FbDVqQ0xlM3J3N1BQTFRNdU5qR1EwR3g1UjZSdkRraThiaXBQQnd0NzN1R0ZXSTlUQ3J3VXJWMzMzTjVoandCS3VGQQ?oc=5","date":"2020-03-11","type":"pipeline","source":"Dermatology Times","summary":"Guidance on transitioning psoriasis patients between biologics - Dermatology Times","headline":"Guidance on transitioning psoriasis patients between biologics","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}